The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
Condition(s):Ovarian NeoplasmsLast Updated:February 5, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Ovarian NeoplasmsLast Updated:February 5, 2024Not yet recruiting
Condition(s):Ovarian CancerLast Updated:January 23, 2023Recruiting
Condition(s):Ovarian CancerLast Updated:January 31, 2024Recruiting
Condition(s):Ovarian Cancer Stage III; Ovarian Cancer Stage IVLast Updated:February 22, 2024Recruiting
Condition(s):Ovarian CancerLast Updated:February 8, 2024Recruiting
Condition(s):Ovarian CancerLast Updated:March 12, 2024Not yet recruiting
Condition(s):Ovarian Cancer; Ovarian Neoplasms; Ovary Cyst; Ovary DiseaseLast Updated:May 10, 2023Recruiting
Condition(s):Patient Reported Outcome Measures; Ovarian NeoplasmsLast Updated:May 5, 2022Recruiting
Condition(s):Ovarian CancerLast Updated:March 19, 2024Not yet recruiting
Condition(s):Ovarian CancerLast Updated:November 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.